Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announces the ...

According to Grand View Research, the European and Middle Eastern drug screening markets are projected to grow significantly by 2030, with Europe expected to reach $3.6 billion and the Middle East and ...

Trinity Biotech plc (NASDAQ: TRIB) recently announced compelling ... and the path to sobriety,” said David Gandini, CEO of SOBRsafe.“With SOBRsure, we provide an accountability tool that not only ...

Ireland punches well above its weight in the semiconductor sphere, both with international giants and successful start-ups.

Sudkate Chaiyo is a Thai chemist who is a researcher at The Institute of Biotechnology and Genetic Engineering ... on solid-state bioelectronics under the mentorship of Professors David Cahen and ...

Enter Telegraph 25, the list of our favourite investment funds. It is a mixture of funds that we believe will grow your money ...

Trinity Biotech ( ($TRIB) ) has shared an update. On February 6, 2025, Trinity Biotech announced significant improvements in its continuous ...

The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more than ...

DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

Shares of TRIB opened at $0.86 on Thursday. Trinity Biotech has a one year low of $0.74 and a one year high of $3.55. The company has a market cap of $15.56 million, a PE ratio of -0.38 and a beta ...